MedTrace Logo

Multicenter Performance Study of QuadQuik Invitro Diagnostic Device

NCT05692505 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-01-20

No results posted yet for this study

Summary

To Demonstrate Clinical Performance of the TriQuik Invitro Diagnostic Device

Conditions

  • HIV Infections
  • Hepatitis C
  • Hepatitis B
  • Syphilis Infection

Interventions

DIAGNOSTIC_TEST

QuadQuik

Invitro diagnostic device

Sponsors & Collaborators

  • Ahsan Awan

    collaborator UNKNOWN

  • Genlantis Diagnostics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-04-01
Completion
2023-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05692505 on ClinicalTrials.gov